OLEMA PHARMACEUTICALS INC (OLMA) Institutional Ownership Changes & 13F Activity
OLEMA PHARMACEUTICALS INC (OLMA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Cormorant Asset Management, Lp, Deep Track Capital, Lp, Point72 Asset Management, L.P., Ameriprise Financial Inc, and Woodline Partners Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -19,592 | -17.9% | 89,990 | $1.13M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -263,504 | -29.1% | 641,828 | $8.03M | Q2 2026 | Sep 02, 2026 |
| Optimize Financial Inc | Sell | -71 | -0.3% | 20,496 | $256.40K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +19,457 | +49.8% | 58,536 | $732.28K | Q2 2026 | Aug 24, 2026 |
| Ensign Peak Advisors, Inc | Sell | -96,782 | -100.0% | 0 | $0.00 | Q2 2026 | Aug 18, 2026 |
| Seven Fleet Capital Management Lp | Buy | +31,476 | — | 31,476 | $393.76K | Q2 2026 | Aug 17, 2026 |
| Jefferies Financial Group Inc. | Buy | +4,000 | +57.1% | 11,000 | $137.61K | Q2 2026 | Aug 17, 2026 |
| Cormorant Asset Management, Lp | Sell | -1,750,000 | -44.9% | 2,150,000 | $26.90M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +1,500,000 | — | 1,500,000 | $18.77M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +999,842 | +1406.1% | 1,070,949 | $13.40M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +840,646 | — | 840,646 | $10.52M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Sell | -731,000 | -49.3% | 751,030 | $9.40M | Q2 2026 | Aug 14, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +650,000 | +8.1% | 8,670,576 | $108.47M | Q2 2026 | Aug 14, 2026 |
| Readystate Asset Management Lp | Buy | +593,829 | — | 593,829 | $7.43M | Q2 2026 | Aug 14, 2026 |
| Defilade Capital Management, L.P. | Sell | -579,778 | -38.5% | 924,758 | $11.57M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +522,390 | +50.0% | 1,567,979 | $19.62M | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Buy | +411,630 | +266.0% | 566,400 | $7.09M | Q2 2026 | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, Llc | Sell | -387,989 | -5.2% | 7,085,249 | $88.64M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -356,267 | -30.1% | 826,569 | $10.34M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +350,507 | +112.1% | 663,319 | $8.30M | Q2 2026 | Aug 14, 2026 |
| Kingdon Capital Management, L.L.C. | Buy | +345,000 | +40.4% | 1,200,000 | $15.01M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Sell | -232,761 | -71.6% | 92,412 | $1.16M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Sell | -215,000 | -35.9% | 383,281 | $4.79M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -173,831 | -34.2% | 334,875 | $4.19M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -160,930 | -56.3% | 124,952 | $1.56M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Sell | -138,233 | -20.8% | 526,446 | $6.59M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -123,082 | -16.7% | 615,470 | $7.70M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +117,412 | — | 117,412 | $1.47M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +70,142 | — | 70,142 | $877.48K | Q2 2026 | Aug 14, 2026 |
| Rock Springs Capital Management Lp | Buy | +64,800 | +38.0% | 235,178 | $2.94M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about OLMA activity
Which institutional owners are buying OLMA?
Institutional owners buying OLMA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OLMA activity?
"Buy" means an investor increased their reported position in OLMA compared to the prior reporting period. This reflects growing exposure to OLEMA PHARMACEUTICALS INC (OLMA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OLMA increasing?
Institutional interest in OLMA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related OLMA Institutional Insights
- OLMA Overview
- OLMA 13F Institutional Holders
- OLMA Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- OLMA Insider Trading & SEC Form 4 Activity
- OLMA Articles
- Top Institutional Investor Stock Rankings